Clearance Summary
LYMPHO SEP(TM) received FDA 510(k) clearance under submission number K902445, sponsored by Icn Biomedicals, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1990-08-22.
- Submission: K902445
- Applicant / Sponsor: Icn Biomedicals, Inc.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class I
- Regulation citation: 21 CFR 864.8500
- Decision date: 1990-08-22
Classification & Regulation
This clearance is catalogued under FDA product code JCF and 21 CFR 864.8500, within the Hematology review panel as a Class I device.